The interactions of tungsten chlorides and oxychlorides with methyl 10-undecenoate, methyl palmitate and methyl acetate, respectively, have been investigated by UV-VIS, IR and EPR spectroscopic methods. The primary complex formed by coordination of the carbonyl group to WCl6 is converted successively to an analogical, very stable complex WOCl4.ester under the simultaneous formation of acyl chloride and methyl chloride. In the case of methyl undecenoate, the coordination reaction is accompanied by a partial reduction of WCl6 to WCl5. The latter reacts with the ester in excess to give a complex characterized by a broad EPR single line at g = 1.767 (ΔH = 7.8 mT). At higher ester-to-tungsten molar ratios, this complex undergoes deeper reduction to products containing tungsten in a lower oxidation state, and competitively, a parallel oxygen abstraction reaction yielding WOCl3, acyl chloride and methyl chloride. The participation of these reactions in the formation of active WCl6-based catalysts for methathesis of unsaturated esters is discussed.
Ring-opening metathesis copolymerization of 5-norbornen-2-yl a) acetate (NBEAc; 80% endo) with cyclooctene (COE) and norbornene b, (NBE) was studied using WCI6/(CH3),Sn as catalytic system. The copolymerization parameters (r, = r2 = 1 for the NBEAc/NBE system and rl = l / r , = 132 for the NBEAc/COE system) show that the reactivity of the monomers is not affected by the presence of an ester substituent but that it depends on the structure of the hydrocarbon cycle. Thus the well known inhibition effect of the ester group may be concluded not to lie in the propagation step of the catalytic cycle.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.